Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212082.RAQbo48Sxz7BcWMI9RGIVK90g5Vdc2kQXw0yodRgBcOAw130_provenance.
• NP257413.RApfQnUo9i83vOxJdWdZ9r2BcFcuYRsmYIfd5ZpfySEKU130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257413.RApfQnUo9i83vOxJdWdZ9r2BcFcuYRsmYIfd5ZpfySEKU130_provenance.
• NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_provenance.
• NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918728.RAQiV-3eNh9QpO3T3Mh77pDUwJ_MybsuSQnbE0lnHJP6Q130_provenance.
• assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP515353.RA-X3_BdxeUPk4sYZZkDE-jf3JPUNkh-WQqhu_JKS-5f8130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515353.RA-X3_BdxeUPk4sYZZkDE-jf3JPUNkh-WQqhu_JKS-5f8130_provenance.
• assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_provenance.
• NP911128.RAVOXfdSgWTL4j7phi-TPjAChK-CzKowE_lpUF9plwnsQ130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911128.RAVOXfdSgWTL4j7phi-TPjAChK-CzKowE_lpUF9plwnsQ130_provenance.
• assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290914.RAAkbtTR2M3086xEI3w3UKGGdcUCHovgsyL11FBJvmbaE130_provenance.
• NP886538.RAFQqPnGnQ0E8FmkO8S8ooIe-IGa8w9QLFjeMDbzxKVWw130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886538.RAFQqPnGnQ0E8FmkO8S8ooIe-IGa8w9QLFjeMDbzxKVWw130_provenance.
• NP400067.RAOykqkz06Yhu4r9tE2RStqTnReVcKf0HqI_GOjsKDXAA130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400067.RAOykqkz06Yhu4r9tE2RStqTnReVcKf0HqI_GOjsKDXAA130_provenance.
• NP400068.RA9yOkyNiCk1ReRxqIVcAH1mc_8UhDxo-vE6BhqqOqDbI130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400068.RA9yOkyNiCk1ReRxqIVcAH1mc_8UhDxo-vE6BhqqOqDbI130_provenance.
• NP400069.RA4hUufL6tEf0NEBC1oN5K5QGgkyJhgk_qzKL4t55xZ8U130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400069.RA4hUufL6tEf0NEBC1oN5K5QGgkyJhgk_qzKL4t55xZ8U130_provenance.